ADVFN US – Market Content Editor
-
Gold Holds Firm as Markets Brace for Fed Decision and Trump’s Tariff Deadline
Gold prices remained largely unchanged during Wednesday’s Asian trading session as investors balanced ongoing U.S. trade uncertainties with anticipation of the Federal Reserve’s upcoming policy announcement. Spot gold slipped marginally by 0.1% to $3,323.66 an ounce, while gold futures fell by the same margin to $3,378.62 per ounce as of 02:18 ET (06:18 GMT). The…
-
Dollar Retreats Slightly Ahead of Fed Meeting; Euro Faces First Monthly Drop of 2025
The U.S. dollar eased a bit on Wednesday, giving back some gains from earlier in the week as markets awaited the Federal Reserve’s upcoming policy decision. At the same time, the euro is positioned to log its first monthly loss of the year. The Dollar Index, which tracks the greenback against six major currencies, was…
-
Stock Market Today: S&P 500 Pulls Back From Record High as Fed Meeting, China Trade Talks Weigh
The S&P 500 slipped on Tuesday after touching a fresh intraday record, as investors navigated a heavy wave of corporate earnings and lingering uncertainty over U.S.-China trade negotiations. At the closing bell (4:00 p.m. ET), the Dow Jones Industrial Average dropped 204 points, or 0.5%, while the S&P 500 eased 0.3% after hitting an all-time…
-
U.S. Stocks Give Back Ground Following Recent Strength
After failing to sustain an early move to the upside, stocks gave back ground over the course of the trading session on Tuesday. The major averages pulled back well off their early highs before ending the day in negative territory. The Dow fell 204.57 points or 0.5 percent to 44,632.99, the Nasdaq declined 80.29 points…
-
U.S. Consumer Confidence Rises, Beats Expectations and Prior Reading
The latest Consumer Confidence data from The Conference Board shows an uptick in consumer sentiment, with the index rising to 97.2—beating both the expected reading of 95.9 and the previous figure of 95.2. This stronger-than-anticipated result reflects growing optimism among U.S. consumers regarding economic conditions. The upward move in the index signals a positive shift…
-
Anghami Shares Drop Following Announcement of 1-for-10 Reverse Stock Split
Shares of Anghami Inc. (NASDAQ:ANGH) declined 9.4% after the company announced it will implement a 1-for-10 reverse stock split in an effort to regain compliance with Nasdaq’s minimum bid price requirements. The leading multimedia streaming platform in the MENA region said its shares will begin trading on a split-adjusted basis on August 4, 2025. The…
-
Spotify Shares Drop 10% After Disappointing Q3 Outlook
Spotify (NYSE:SPOT) shares fell more than 10% in early U.S. trading on Tuesday after the company issued weaker-than-expected guidance for the current quarter, citing currency headwinds and rising payroll costs. While analysts have increasingly focused on Spotify’s profitability after years of user growth prioritization, the company continues to face mounting expenses—particularly related to personnel. In…
-
ScanTech AI Shares Skyrocket After Gaining Access to Government Procurement Platform
Shares of ScanTech AI Systems Inc. (NASDAQ: STAI) soared more than 80% on Tuesday following news of a strategic partnership that grants the company access to public sector procurement through The Interlocal Purchasing System (TIPS). The developer of advanced security screening technologies has entered into a TIPS contract via a collaboration with Creeksource Consulting LLC.…
-
Coastal Financial Shares Slide After Q2 Earnings Miss Expectations
Coastal Financial Corporation (NASDAQ:CCB) shares dropped 4.3% on Tuesday after the company reported second-quarter results that came in below analyst forecasts on both revenue and earnings. For the quarter ending June 30, 2025, Coastal reported net income of $11.0 million, or $0.71 per diluted share—falling short of the $0.84 per share expected by analysts. Revenue…
-
Kiniksa Pharmaceuticals Shares Climb 11% After Earnings Beat and Upgraded Outlook
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) saw its stock rise 11.4% after posting second-quarter results that topped Wall Street expectations and lifting its full-year revenue forecast, driven by continued momentum for its ARCALYST therapy. The company reported adjusted earnings per share of $0.23 for the quarter, ahead of the $0.19 expected by analysts. Revenue came in at…